welcomes you to the new, improved website!This randomized trial evaluated the efficacy of postoperative metoprolol or losartan in preventing atrial fibrillation in patients with elevated N-terminal pro-brain natriuretic peptide who were undergoing lung resection for cancer. Among candidates, 29% (320) of patients had elevated NT-proBNP and were randomized. Both metoprolol and losartan reduced afib incidence compared to controls (6%, 12%, 40%).
You are here:
Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial
Submitted by: Mark Ferguson
Source: Annals of Surgery
Keywords:
Author(s): Cardinale, Daniela; Sandri, Maria T; Colombo, Alessandro; Salvatici, Michela; Tedeschi, Ines; Bacchiani, Giulia; Beggiato, Marta; Meroni, Carlo A; Civelli, Maurizio; Lamantia, Giuseppina; Colombo, Nicola; Veglia, Fabrizio; Casiraghi, Monica; Spaggiari, Lorenzo; Venturino, Marco; Cipolla, Carlo M
